Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guirui Yan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 5, 2010
DC260126, a small-molecule antagonist of GPR40, improves insulin tolerance but not glucose tolerance in obese Zucker ratsXiaodong Zhang, Guirui Yan, Yiming Li, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2010
Discovery of highly selective inhibitors of human fatty acid binding protein 4 (FABP4) by virtual screeningHaiyan Cai, Guirui Yan, Xiaodong Zhang, et al.
Diabetes, Obesity & Metabolism|January 20, 2026
Efsubaglutide Alfa attenuates metabolic dysfunction-associated steatohepatitis in mice with improvements in second harmonic generation-derived fibrosis featuresYahao Wang, Zhihong Wang, Guirui Yan, et al.
Biochemical and Biophysical Research Communications|May 18, 2010
Sildenafil promotes adipogenesis through a PKG pathwayXiaodong Zhang, Jun Ji, Guirui Yan, et al.
Journal of Cellular Biochemistry|March 24, 2012
PDE5 inhibitor promotes melanin synthesis through the PKG pathway in B16 melanoma cellsXiaodong Zhang, Guirui Yan, Jun Ji, et al.
Planta Medica|June 28, 2013
Dodoviscin a inhibits melanogenesis in mouse b16-f10 melanoma cellsGuirui Yan, Jingjie Zhu, Laibin Zhang, et al.
Plos One|April 14, 2017
Defective enamel and bone development in sodium-dependent citrate transporter (NaCT) Slc13a5 deficient miceArmando R Irizarry, Guirui Yan, Qingqiang Zeng, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2012
Combining pharmacophore, docking and substructure search approaches to identify and optimize novel B-RafV600E inhibitorsZhijian Xu, Guirui Yan, Gaihong Wang, et al.
European Journal of Medicinal Chemistry|December 3, 2014
Novel fatty acid binding protein 4 (FABP4) inhibitors: virtual screening, synthesis and crystal structure determinationHaiyan Cai, Qiufeng Liu, Dingding Gao, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 5, 2010
DC260126, a small-molecule antagonist of GPR40, improves insulin tolerance but not glucose tolerance in obese Zucker ratsXiaodong Zhang, Guirui Yan, Yiming Li, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2010
Discovery of highly selective inhibitors of human fatty acid binding protein 4 (FABP4) by virtual screeningHaiyan Cai, Guirui Yan, Xiaodong Zhang, et al.
Diabetes, Obesity & Metabolism|January 20, 2026
Efsubaglutide Alfa attenuates metabolic dysfunction-associated steatohepatitis in mice with improvements in second harmonic generation-derived fibrosis featuresYahao Wang, Zhihong Wang, Guirui Yan, et al.
Biochemical and Biophysical Research Communications|May 18, 2010
Sildenafil promotes adipogenesis through a PKG pathwayXiaodong Zhang, Jun Ji, Guirui Yan, et al.
Journal of Cellular Biochemistry|March 24, 2012
PDE5 inhibitor promotes melanin synthesis through the PKG pathway in B16 melanoma cellsXiaodong Zhang, Guirui Yan, Jun Ji, et al.
Planta Medica|June 28, 2013
Dodoviscin a inhibits melanogenesis in mouse b16-f10 melanoma cellsGuirui Yan, Jingjie Zhu, Laibin Zhang, et al.
Plos One|April 14, 2017
Defective enamel and bone development in sodium-dependent citrate transporter (NaCT) Slc13a5 deficient miceArmando R Irizarry, Guirui Yan, Qingqiang Zeng, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2012
Combining pharmacophore, docking and substructure search approaches to identify and optimize novel B-RafV600E inhibitorsZhijian Xu, Guirui Yan, Gaihong Wang, et al.
European Journal of Medicinal Chemistry|December 3, 2014
Novel fatty acid binding protein 4 (FABP4) inhibitors: virtual screening, synthesis and crystal structure determinationHaiyan Cai, Qiufeng Liu, Dingding Gao, et al.
Pageof 1